Dagouassat M, Suffee N,Hlawaty H, Haddad O, Charni F, Laguillier C, Vassy R, Martin L, Schischmanoff P.O., Gattegno L, Oudar O, Sutton A, Charnaux N. Monocyte chemoattractant protein-1 (MCP-1)/CCL2 secreted by hepatic myofibroblasts promotes migration and invasion of human hepatoma cells. Int J Cancer, 2010; 126 (5):1095-108

Cottart C-H, Nivet-Antoine V, Laguillier C, Beaudeux J-L. Resveratrol bioavailability and toxicity in humans. Mol. Nutr. Food Res.2010;54:7-16

Baran-Marszak F, Boukhiar M, Harel S, Laguillier C, Roger C, Gressin R, Martin A, Fagard R, Varin-Blank N, Ajchenbaum-Cymbalista F, Ledoux D. Constitutive and B-cell receptor-induced activation of STAT3 are important signaling pathways targeted by bortezomib in leukemic mantle cell lymphoma. Haematologica, 2010;95:1865-72.

Charni F, Friand V, Haddad O, Hlawaty H, Martin L, Vassy R, Oudar O, Gattegno L, Charnaux N, Sutton A.Syndecan-1 and syndecan-4 are involved in RANTES/CCL5-induced migration and invasion of human hepatoma cells. Biochim Biophys Acta.2009; 1790 (10):1314-26

Friand V, Haddad O, Papy-Garcia D, Hlawaty H,Vassy R, Hamma-Kourbali Y, Perret G.Y.,Courty J,Baleux F, Gattegno L, Sutton A, Charnaux N. Glycosaminoglycan mimetics inhibit SDF-1/CXCL12-mediated migration and invasion of human hepatoma cells. Glycobiology, 2009; 19 (12):1511-24

Hlawaty H, Jacob MP, Louedec L, Letourneur D, Brink C, Michel JB, Feldman L, Bäck M. Leukotriene receptor antagonism and the prevention of extracellular  matrix degradation during atherosclerosis and in-stent stenosis. ATVB, 2009; 29 (4):518-524

Hlawaty H, San Juan A, Bäck M, Jacob MP, Vranckx R, Letourneur D, Feldman LJ.Local MMP2-gene knockdown in balloon-injured rabbit carotid arteries using non viral-siRNA transfection.J Gene Med. 2009; 11 (1):92-9

San Juan A, M Bala, Hlawaty H, Portes P, Vranckx R, Feldman LJ, Letourneur D. Development of a Functionalized Polymer for Stent Coating in the Arterial Delivery of Small Interfering RNA. Biomacromolecules, 2009; 10 (11):3074-80

Suffee N, Richard B, Hlawaty H, Oudar O, Charnaux N, Sutton A.Angiogenic properties of the chemokine RANTES/CCL5. Biochem Soc Trans. 2011; (6):1649-53

Hlawaty H,Suffee N, Sutton A, Oudar O, Haddad O, Olivier V, Laguillier-Morizot C, Gattegno L, Letourneur D, Charnaux N. Low molecular fucoidan prevents intimal hyperplasia in rat injured thoracic aorta through the modulation of matrix metalloproteinase-2 expression. Biochemical Pharmacology, 2011; 81 (2):233-43

Hebert-Schuster M, Cottart C-H, Laguillier-Morizot C, Raynaud-Simon A, Golmard J-L, Fabre E-E, Cynober L, Beaudeux J-L, Nivet-Antoine V. Catalase rs769214 SNP in elderly malnutrition and during renutrition: is glucagon to blame? Free Radic Biol Med. 2011;51:1583-8

Charni F, Sutton A, Rufat P, Laguillier C, Mansouri A, Moreau R, Ganne-Carrie N, Trinchet JC, Beaugrand M, Charnaux N, Nahon P. Chemokine RANTES promoter dimorphisms and hepatocellular occurrence in patients with alcoholic or HCV-related cirrhosis. Cancer Epidemiol Biomarkers Prev. 2011;20:1439-46

Bouton M-C, Boulaftali Y, Richard B, Arocas V, Michel J-B, Jandrot-Perrus M. Emerging role of serpine2/protease nexin-1 in hemostasis and vascular biology. Blood. 2012;119:2452-2457

Briane D, Slimani H, Tagounits A, Naejus R, Haddad O, Coudert R, Charnaux N, Cao A. Inhibition of VEGF expression in A431 and MDA-MB-231 tumour cells by cationic lipid-mediated sirna delivery. Journal of Drug Targeting. 2012;20:347-354

Couvert P, Carrié A, Tezenas du Montcel S, Vaysse J, Sutton A, Barget N, Trinchet J-C, Beaugrand M, Ganne N, Giral P, Chelly J. Insulin-like growth factor 2 gene methylation in peripheral blood mononuclear cells of patients with hepatitis c related cirrhosis or hepatocellular carcinoma. Clinics and Research in Hepatology and Gastroenterology. 2012;36:345-351

Guyot E, Coumoul X, Chassé J-F, Khallouki F, Savouret JF, Poirot M, Barouki R. Identification of a new stilbene-derived inducer of paraoxonase 1 and ligand of the aryl hydrocarbon receptor. Biochemical Pharmacology. 2012;83:627-632

Loire P, Vicaut E, Cruaud P, Charnaux N, Carbillon L. Limited value of angiogenic factors in obese women. Pregnancy Hypertension. 2012;2:368-370

Suffee N, Hlawaty H, Meddahi-Pelle A, Maillard L, Louedec L, Haddad O, Martin L, Laguillier C, Richard B, Oudar O, Letourneur D, Charnaux N, Sutton A. RANTES/CCL5-induced pro-angiogenic effects depend on CCR1, CCR5 and glycosaminoglycans. Angiogenesis.2012;4:727-744.

Nahon P, Sutton A, Rufat P, Charnaux N, Mansouri A, Moreau R, Ganne-Carrié N, Grando-Lemaire V, N'Kontchou G, Trinchet J-C, Pessayre D, Beaugrand M. A variant in myeloperoxidase promoter hastens the emergence of hepatocellular carcinoma in patients with hcv-related cirrhosis. Journal of Hepatology. 2012;56:426-432

Selbonne S, Azibani F, Iatmanen S, Boulaftali Y, Richard B, Jandrot-Perrus M, Bouton M-C, Arocas V.In vitro and in vivo antiangiogenic properties of the serpin protease nexin-1.Molecular and Cellular Biology. 2012;32:1496-1505

Touvier M, Fezeu L, Ahluwalia N, Julia C, Charnaux N, Sutton A, Méjean C, Latino-Martel P, Hercberg S, Galan P, Czernichow S. Pre-diagnostic levels of adiponectin and soluble vascular cell adhesion molecule-1 are associated with colorectal cancer risk. World Journal of Gastroenterology. 2012;18:2805-2812

Touvier M, Kesse-Guyot E, Andreeva VA, Fezeu L, Charnaux N, Sutton A, Druesne-Pecollo N, Hercberg S, Galan P, Zelek L, Latino-Martel P, Czernichow S. Modulation of the association between plasma intercellular adhesion molecule-1 and cancer risk by n-3 pufa intake: A nested case-control study. The American Journal of Clinical Nutrition. 2012;95:944-950

Trepo E, Guyot E, Ganne-Carrie N, Degre D, Gustot T, Franchimont D, Sutton A, Nahon P, Moreno C. PNPLA3 (rs738409 c>g) is a common risk variant associated with hepatocellular carcinoma in alcoholic cirrhosis. Hepatology (Baltimore, Md.). 2012;55:1307-1308

Usachov V, Nahon P, Lunova M, Ziol M, Rufat P, Sutton A, Beaugrand M, Strnad P. Keratin 8 variants are infrequent in patients with alcohol-related liver cirrhosis and do not associate with development of hepatocellular carcinoma. BMC gastroenterology. 2012;12:147

David C, D'Andrea C, Lancelot E, Bochterle J, Guillot N, Fazio B, Maragò OM, Angela Sutton A, Charnaux N, Neubrech F, Pucci A,Gucciardi PG, Lamy de la Chapelle M.Raman and IR spectroscopy of manganese superoxide dismutase, a pathology biomarker. Vibrational spectroscopy. 2012;62:50-58.